Teresa Cleary - Elixinol Wellness Global General Counsel, Company Secretary
| E8M Stock | EUR 0.02 0 10.00% |
Insider
Teresa Cleary is Global General Counsel, Company Secretary of Elixinol Wellness Limited since 2019.
| Tenure | 5 years |
| Phone | 61 2 4044 4585 |
| Web | https://www.elixinolwellness.com |
Elixinol Wellness Management Efficiency
The company has return on total asset (ROA) of (0.3266) % which means that it has lost $0.3266 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7075) %, meaning that it generated substantial loss on money invested by shareholders. Elixinol Wellness' management efficiency ratios could be used to measure how well Elixinol Wellness manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Constantine Saroukos | Takeda Pharmaceutical | 52 | |
| WingYu Leung | CanSino Biologics | 49 | |
| Yonghui Wu | CanSino Biologics | N/A | |
| Aifeng Lyu | HANSOH PHARMAC HD 00001 | 42 | |
| Barbara Weiland | Merck Company | 49 | |
| Xiao Zhi | CanSino Biologics | 40 | |
| Ryouichi Murata | Tsumura Co | N/A | |
| Kai Beckmann | Merck Company | 58 | |
| Shiu Wai | CanSino Biologics | 55 | |
| Min Hu | HANSOH PHARMAC HD 00001 | 42 | |
| Gerhard Schmitz | Merck Company | 60 | |
| Shuichi Takeda | Tsumura Co | N/A | |
| Chuanhe Xu | HANSOH PHARMAC HD 00001 | 55 | |
| Terukazu Kato | Tsumura Co | N/A | |
| Shinichi Murayama | Hisamitsu Pharmaceutical Co | 56 | |
| Mitsuru Nakata | Tsumura Co | N/A | |
| Cuifang Ma | HANSOH PHARMAC HD 00001 | 43 | |
| Matthias Heinzel | Merck Company | 56 | |
| Constantin Fest | Merck Company | 46 | |
| Gabriele Ricci | Takeda Pharmaceutical | 45 | |
| Ming Chiu | CanSino Biologics | 42 | |
Management Performance
| Return On Equity | -0.71 | |||
| Return On Asset | -0.33 |
Elixinol Wellness Leadership Team
Elected by the shareholders, the Elixinol Wellness' board of directors comprises two types of representatives: Elixinol Wellness inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elixinol. The board's role is to monitor Elixinol Wellness' management team and ensure that shareholders' interests are well served. Elixinol Wellness' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elixinol Wellness' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Greg Smith, Global Chief Information Officer | ||
| Kim BradleyWare, Joint Sec | ||
| Oliver Horn, Chief Executive Officer, Director | ||
| Glen Zurcher, Account Department | ||
| Paul Benhaim, Non-Executive Chairman of the Board | ||
| Leif Harrison, Chief Executive Officer of America | ||
| Teresa Cleary, Global General Counsel, Company Secretary | ||
| Rob Hasselman, Pres Americas | ||
| Gabriel Ettenson, Global Chief Technology Officer | ||
| Helen Wiseman, Non-Executive Chairman of the Board | ||
| FCPA BEC, Interim Officer | ||
| Ali Atcha, Chief Executive Officer of Europe & UK | ||
| Josephine Lorenz, Global Controller | ||
| Linda McLeod, Managing Director | ||
| Ron Dufficy, Global Chief Financial Officer | ||
| Beata Silber, Global Innovation |
Elixinol Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Elixinol Wellness a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.71 | |||
| Return On Asset | -0.33 | |||
| Profit Margin | (1.72) % | |||
| Operating Margin | (1.63) % | |||
| Current Valuation | 1.96 M | |||
| Shares Outstanding | 316.27 M | |||
| Shares Owned By Insiders | 15.67 % | |||
| Shares Owned By Institutions | 4.83 % | |||
| Price To Book | 0.54 X | |||
| Price To Sales | 0.50 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Elixinol Stock
Elixinol Wellness financial ratios help investors to determine whether Elixinol Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Elixinol with respect to the benefits of owning Elixinol Wellness security.